Today: 20 May 2026
LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock
8 February 2026
1 min read

LSEG share price heads into Monday after AI jitters hit London Stock Exchange Group stock

London, February 8, 2026, 08:19 GMT — Markets aren’t open at this hour.

  • London Stock Exchange Group wrapped up Friday at 7,502p, down 1.1%.
  • Data and analytics shares have swung sharply as fresh worries about AI disruption hit the sector.
  • On deck: traders eye Monday’s open. LSEG’s FY25 preliminary results webcast lands Feb. 26.

London Stock Exchange Group (LSEG.L) ended Friday at 7,502 pence, down 1.1%. The stock bounced between 7,184 and 7,716 pence during the day. Volume landed near 2.2 million shares. For the week, LSEG dropped roughly 8%.

LSEG shares took a hit this week, fueling a fierce debate among traders about whether fresh “AI agents” could start chipping away at the pricing power that data and workflow firms rely on. Reuters reported additional selling pressure after Anthropic’s Claude rolled out a new plug-in, and nerves rattled further as investors digested the sheer scale of Big Tech’s current AI investment wave. “Headlines that would have pushed shares to fresh highs… are now being interpreted far more cautiously,” said Carlota Estragues Lopez, equity strategist at St. James’s Place. Reuters

The gap inside the AI trade keeps widening. Chipmakers and hardware firms are grabbing gains on the infrastructure boom. Meanwhile, a growing group of names is being marked as exposed to AI’s encroachment. “This divergence is not a vote against AI,” wrote Charu Chanana, chief investment strategist at Saxo, who sees investors starting to separate “who enables AI and who may be disrupted.” Mark Hawtin at Liontrust put it bluntly: “The market is no longer tolerating spending for spending’s sake.” Reuters

The FTSE 100 in London nudged up 0.6% on Friday, according to Reuters, as gains among banking names outweighed weakness in data and analytics stocks. LSEG slipped for a third week in a row.

LSEG bought back 256,419 shares on Feb. 5, paying an average of 7,533.05 pence apiece. The move follows the buyback program it launched on Nov. 4, 2025. These shares are headed for cancellation. Reducing the share count usually lifts earnings per share, but it has no effect on demand for LSEG’s products.

Focus remains on whether the selloff in “AI-exposed” data stocks will ease or pick up steam once London trading resumes on Monday. U.S. megacaps have been driving the action, as fresh cues on AI capital spending continue to sway risk appetite.

The risk remains. If customers shift fast to cheaper AI alternatives and incumbents can’t hold on to their margins, valuations may keep taking hits from investors. In that picture, buybacks provide scant protection.

LSEG’s preliminary full-year 2025 results are on the calendar for Feb. 26, with CEO David Schwimmer and CFO Michel-Alain Proch taking the lead on the webcast.

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next
Previous Story

Zhongji Innolight stock slides nearly 4% into China’s Monday open — what traders watch next

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop